Investigational Cancer Therapeutics
Phase I Clinical Trials Program
At this site, you can learn more about the Phase I Clinical Trials Program in the Department of Investigational Cancer Therapeutics and the services we provide as well as gain information about some of our new Phase I clinical trials by viewing the program's newsletter.
We strive to provide outstanding patient care while performing innovative Phase I trials with new drugs that may eventually improve the management of cancer.
Our growing program is becoming a centralized resource for patients, physicians and scientists who are looking for new experimental Phase I therapies that may eventually represent advances in cancer research and treatment.
You also can learn about our Clinical Center for Targeted Therapy, which is dedicated to providing excellent care for our patients by bringing the newest agents for cancer treatment more quickly from the laboratory to clinical trials. For specific referrals, go to the Contact Information page.
Appointments & Referrals
For a referral to clinical trials with a new targeted drug, call (713) 792-1160, or visit our Contact Information page.